Angiographic Insights from Optical Coherence Tomography in Attention Deficit Hyperactivity Disorder
Clinical Scorecard: Angiographic Insights from Optical Coherence Tomography in Attention Deficit Hyperactivity Disorder
At a Glance
Category Detail
Condition Attention Deficit Hyperactivity Disorder (ADHD) Key Mechanisms Neurotransmitter dysregulation, particularly dopamine, affecting visual and retinal functions. Target Population Adults diagnosed with ADHD, receiving methylphenidate treatment. Care Setting Ophthalmology and Neuropsychiatry Departments
Key Highlights
ADHD affects approximately 2.5% of the global population. OCT angiography reveals significant retinal thickness and vascular density differences in ADHD patients compared to controls. Dopamine's role in visual processing links ADHD to retinal abnormalities. Guideline-Based Recommendations
Diagnosis
Utilize the Wender Utah Rating Scale for ADHD assessment. Management
Methylphenidate is the primary treatment for ADHD. Monitoring & Follow-up
Regular ocular examinations and OCT angiography to assess retinal health. Risks
Exclude patients with comorbid conditions that may affect retinal or brain health. Patient & Prescribing Data
Adults with ADHD, diagnosed since childhood.
Patients should be on methylphenidate for at least six months prior to assessment.
Clinical Best Practices
Conduct comprehensive ocular examinations in ADHD patients. Use OCT angiography for detailed assessment of retinal structure and vascularity. Related Resources & Content
